28 results on '"Zimran, Eran"'
Search Results
2. OA-34 Feasibility of a novel academic anti-BCMA chimeric antigen receptor T-cell (CART) (HBI0101) for the treatment of relapsed and refractory AL amyloidosis
3. P-026 Safety and efficacy of a locally produced novel anti-BCMA chimeric antigen receptor T-cell (CART) (HBI0101) for the treatment of relapsed and refractory multiple myeloma
4. High rate of adenovirus detection in gastrointestinal biopsies of symptomatic stem cell transplant recipients
5. Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell Transplantation
6. Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?
7. ATG-F Versus ATG-T for Graft Versus Host Disease Prevention in Allogeneic Stem Cell Transplantation: A Retrospective Comparative Study
8. Tecam (Thiotepa, Etoposide, cyclophosphamide, Cytarabine and Melphalan) Is an Effective and Safe Conditioning Regimen for Autologous Transplant in Lymphoma
9. Letermovir Prophylaxis for High-Risk Allogenic Transplantation Recipients, Real- World Israeli Experience
10. Development and manufacturing of novel locally produced anti-BCMA CART cells for the treatment of relapsed/refractory multiple myeloma: phase I clinical results
11. Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis
12. Re-induction versus salvage for D14-resiudal acute myeloid leukemia: A retrospective multi-center study
13. Mesenchymal stroma/stem cells: Haematologists’ friend or foe?
14. Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma
15. Neutrophil decline rate following autologous transplant for lymphoma is a predictor of patients’ outcome
16. COVID-19 Among Patients with Hematological Malignancies: Experience from a Tertiary Center Showing Lower Than Expected Mortality and Establishing the Safety of in-Hospital Patient Care during the Pandemic
17. Ex vivo expansion of hematopoietic stem cells: Finally transitioning from the lab to the clinic
18. COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome
19. Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor
20. Novel treatments to tackle myelofibrosis
21. Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation
22. Dysregulated iron metabolism in polycythemia vera: etiology and consequences
23. Genomic characterization of spleens in patients with myelofibrosis
24. Current approaches to challenging scenarios in myeloproliferative neoplasms
25. The Exhaustion of Adult Hematopoietic Stem Cells in Ex Vivo Cultures Can Be Overcome by a Histone Deacetylase Inhibitor
26. Valproic Acid Expands the Numbers of HSCs from Cord Blood CD34+ Cells By Linking Epigenetic Modifications to Mitochondrial Remodeling and p53 Upregulation
27. Paradoxical response in ocular bartonellosis
28. Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.